Should we do more to improve oral contraceptive continuation?
Castaño, P.M.; White, K.O.'C.
Women's Health 9(2): 145-156
2013
ISSN/ISBN: 1745-5065 PMID: 23477321 DOI: 10.2217/whe.13.10Document Number: 567088
Oral contraceptives are commonly chosen methods whose contraceptive effectiveness is very user-dependent. Approaches to significantly improving oral contraceptive continuation have been largely unsuccessful. Long-acting reversible methods are the most highly effective reversible contraceptives, with the highest continuation rates, and should be the first-line methods offered to reproductive-aged women.
Document emailed within 0-6 h
Related Documents
McClain Burke, H.; Ambasa-Shisanya, C. 2014: Evaluation of a communication campaign to improve continuation among first-time injectable contraceptive users in Nyando District, Kenya International Perspectives on Sexual and Reproductive Health 40(2): 56-67White, K.O.'C.; Westhoff, C. 2011: The effect of pack supply on oral contraceptive pill continuation: a randomized controlled trial Obstetrics and Gynecology 118(3): 615-622
Sapkota, S.; Rajbhandary, R.; Lohani, S. 2017: The Impact of Balanced Counseling on Contraceptive Method Choice and Determinants of Long Acting and Reversible Contraceptive Continuation in Nepal Maternal and Child Health Journal 21(9): 1713-1723
Iwata, M.Chiharu.; Porquere, L.; Sorpreso, I.C.Espósito.; Baracat, E.C.; Soares Júnior, Jé.Maria. 2015: Association of oral contraceptive and metformin did not improve insulin resistance in women with polycystic ovary syndrome Revista da Associacao Medica Brasileira 61(3): 215-219
Nyberg, S. 2013: Mood and physical symptoms improve in women with severe cyclical changes by taking an oral contraceptive containing 250-mcg norgestimate and 35-mcg ethinyl estradiol Contraception 87(6): 773-781
Briggs, P.; Serrani, M.; Vogtländer, K.; Parke, S. 2016: Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study International Journal of Women's Health 8: 477-487
Briggs, P.; Serrani, M.; Vogtländer, K.; Parke, S. 2016: Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study International Journal of Women's Health 8: 477-487
Smit, J.A.; Beksinska, M.E. 2013: Hormonal contraceptive continuation and switching in South Africa: implications for evaluating the association of injectable hormonal contraceptive use and HIV Journal of Acquired Immune Deficiency Syndromes 62(3): 363-365
Smit, J.A.; Beksinska, M.E. 2013: Hormonal contraceptive continuation and switching in South Africa: implications for evaluating the association of injectable hormonal contraceptive use and HIV Journal of Acquired Immune Deficiency Syndromes 62(3): 363-365
Smit, J.A.; Beksinska, M.E. 2013: Hormonal contraceptive continuation and switching in South Africa: implications for evaluating the association of injectable hormonal contraceptive use and HIV Journal of Acquired Immune Deficiency Syndromes 62(3): 363-365
Elassar, A.; Nulsen, J.; Engmann, L.; Benadiva, C. 2015: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does it Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Journal of Reproductive Medicine 60(5-6): 199-204
Khalifa, A.M.; Sayed, H.A.; El-khorazaty, M.N.; Way, A.A. 1982: Prevalence, continuation and availability of contraceptive methods: a summary of the results of the Egypt Contraceptive Prevalence Survey Egyptian Population and Family Planning Review 16(2): 1-31
Khalifa, A.M.; Sayed, H.A.; El-khorazaty, M.N.; Way, A.A. 1982: Prevalence, continuation and availability of contraceptive methods: a summary of the results of the Egypt Contraceptive Prevalence Survey Egyptian Population and Family Planning Review 16(2): 1-31
Khalifa, A.M.; Sayed, H.A.; El-khorazaty, M.N.; Way, A.A. 1982: Prevalence, continuation and availability of contraceptive methods: a summary of the results of the Egypt Contraceptive Prevalence Survey Egyptian Population and Family Planning Review 16(2): 1-31
Khalifa, A.M.; Sayed, H.A.; El-khorazaty, M.N.; Way, A.A. 1982: Prevalence, continuation and availability of contraceptive methods: a summary of the results of the Egypt Contraceptive Prevalence Survey Egyptian Population and Family Planning Review 16(2): 1-31
Khalifa, A.M.; Sayed, H.A.; El-khorazaty, M.N.; Way, A.A. 1982: Prevalence, continuation and availability of contraceptive methods: a summary of the results of the Egypt Contraceptive Prevalence Survey Egyptian Population and Family Planning Review 16(2): 1-31
Khalifa, A.M.; Sayed, H.A.; El-khorazaty, M.N.; Way, A.A. 1982: Prevalence, continuation and availability of contraceptive methods: a summary of the results of the Egypt Contraceptive Prevalence Survey Egyptian Population and Family Planning Review 16(2): 1-31
Khalifa, A.M.; Sayed, H.A.; El-khorazaty, M.N.; Way, A.A. 1982: Prevalence, continuation and availability of contraceptive methods: a summary of the results of the Egypt Contraceptive Prevalence Survey Egyptian Population and Family Planning Review 16(2): 1-31
Khalifa, A.M.; Sayed, H.A.; El-khorazaty, M.N.; Way, A.A. 1982: Prevalence, continuation and availability of contraceptive methods: a summary of the results of the Egypt Contraceptive Prevalence Survey Egyptian Population and Family Planning Review 16(2): 1-31
Khalifa, A.M.; Sayed, H.A.; El-khorazaty, M.N.; Way, A.A. 1982: Prevalence, continuation and availability of contraceptive methods: a summary of the results of the Egypt Contraceptive Prevalence Survey Egyptian Population and Family Planning Review 16(2): 1-31